ONFI 2.5 MG/ML SUSPENSION
FDA nonproprietary name: clobazam
For 120 mL
Pharmacies pay
$1,496.77 filed
120 × $12.47305 per ML
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$1,726.29 estimated
$1,496.77 + $224.52 (15%) + $5.00 fee per fill = $1,726.29
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
ONFI 2.5 MG/ML SUSPENSION is how the CMS NADAC file names this product. The FDA NDC Directory lists it as clobazam, under the trade name “Onfi”.
FDA gives its dosage form as suspension and its route as oral.
The labeler, the company named on the label, is Lundbeck Pharmaceuticals LLC.
FDA’s Established Pharmacologic Class for it is Benzodiazepine.
The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 67386-0313-21.
NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $1,496.77 for 120 mL (120 × $12.47305 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.
NADAC also lists, on the row of one brand NDC, what pharmacies pay for the generic equivalent, a different product: $0.17304 per ML filed.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What NADAC measures · NADAC explanation codes
The NDC
- 67386-0313-21 · Lundbeck Pharmaceuticals LLC · $12.47305 per ML · eff. 2026-09-23 filed
Other strengths, forms and brands
8 other products in the NADAC file share the FDA nonproprietary name clobazam with ONFI 2.5 MG/ML SUSPENSION.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| CLOBAZAM 2.5 MG/ML SUSPENSION | $0.17304 per ML filed | We don’t know yet |
| CLOBAZAM 10 MG TABLET | $0.24265 per EA filed | We don’t know yet |
| CLOBAZAM 20 MG TABLET | $0.43208 per EA filed | We don’t know yet |
| ONFI 2.5 MG/ML SUSPENSION this page | $12.47305 per ML filed | We don’t know yet |
| ONFI 10 MG TABLET | $29.91293 per EA filed | We don’t know yet |
| ONFI 20 MG TABLET | $59.81597 per EA filed | We don’t know yet |
| SYMPAZAN 5 MG FILM | $16.40306 per EA filed | $33.56637 per EA filed |
| SYMPAZAN 10 MG FILM | $32.75766 per EA filed | $33.56637 per EA filed |
| SYMPAZAN 20 MG FILM | $65.42818 per EA filed | $33.56637 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-04-01, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
Its NADAC price is $12.47305 per ML filed.
Of the 13 other products in FDA’s Benzodiazepine class priced per ML, 0 have a higher middle NADAC price and 13 a lower one. The one in the middle is LORAZEPAM 2 MG/ML ORAL CONCENT, at $0.68632 per ML filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 120 mL? Is it lower than what I would pay through my insurance?
- Is a generic version available, and would it suit me? NADAC lists a generic with the same ingredient, strength and dosage form by FDA: CLOBAZAM 2.5 MG/ML SUSPENSION. Ask your pharmacist or prescriber; do not switch on your own.
- How much is in the package I am getting? This page uses 120 mL; your package may hold a different amount.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why does this page start at 120 mL?
- NADAC prices this product per ML. The FDA NDC Directory’s package description gives 120 mL in one package for this product’s NDC (“1 BOTTLE in 1 CARTON (67386-313-21) / 120 mL in 1 BOTTLE”), so the card starts at one package: 120 ML. Change it to match your prescription.
Related pages
Its pharmacologic class
Related in the same class
- ALPRAZOLAM 0.25 MG TABLET
- CLONAZEPAM 0.5 MG TABLET
- DIAZEPAM 10 MG TABLET
- TEMAZEPAM 15 MG CAPSULE
- CLORAZEPATE 15 MG TABLET